Hereditary Cancer & Tumor Predisposition Clinic
At the Emory Hereditary Cancer & Tumor Predisposition Clinic, patients are seen by a geneticist and a genetic counselor for evaluation, counseling, and genetic testing for complex personal and family histories of rare cancers/tumors.
We provide ongoing medical management for patients who have been diagnosed with rare hereditary cancer or tumor syndromes, including:
· Li-Fraumeni syndrome (TP53 gene)
· Hereditary paraganglioma-pheochromocytoma syndrome (SDHA, SDHAF2, SDHB, SDHC, SDHD, TMEM127, MAX genes)
· Multiple endocrine neoplasia (MEN1, RET, CDKN1B genes)
· Von Hippel-Lindau syndrome (VHL gene)
· Birt-Hogg-Dubé Syndrome (FLCN gene)
· Hereditary leiomyomatosis and renal cell cancer syndrome (FH gene)
· Gorlin syndrome/nevoid basal cell carcinoma syndrome (SUFU, PTCH1 genes)
· Familial adenomatous polyposis syndrome (APC gene)
This clinical care may include office visits every 1-3 years, screenings (such as imaging studies, comprehensive physical examinations, and/or blood work), coordination of care with your other providers, resources for additional psychological support, and referrals to additional appropriate specialists.
